Evidence map›Paper›PMID 36009920›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Transcriptomic and Metabolomic Analysis of a Fusidic Acid-Selected

Sushim K Gupta, Richard F Pfeltz, Brian J Wilkinson, John E Gustafson

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Clinical Features and Antibiotic Susceptibility ofJournal of clinical medicine · 2025
    Article
  4. Repurposing fusidic acid as an antimicrobial against enterococci with a low probability of resistance development.International microbiology : the official journal of the Spanish Society for Microbiology · 2024
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Sushim K GuptaDepartment of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, OK 74078, USA.
Richard F PfeltzBD Life Sciences, Microbiology Research and Development, Sparks, MD 21152, USA.
Brian J WilkinsonSchool of Biological Sciences, Illinois State University, Normal, IL 61761, USA.
John E GustafsonDepartment of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, OK 74078, USA.ORCID 0000-0002-1870-6912
Illinois State University · USNew Mexico State University · USOklahoma State University · US

Funding

ZUNI HEALTH INITIATIVE-PILOT STUDYP20RR016480 · NCRR · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI GRIFFITH, JEFFREY K · 2001 to 2011
$33.7M
Translational Control in the Hepatitis C VirusS06GM008136 · NIGMS · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI KUEHN, GLENN D · 1989 to 2011
$23.2M
RISE PROGRAM AT NEW MEXICO STATE UNIVERSITYR25GM061222 · NIGMS · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI HOUSTON, JESSICA PEREA, REDDI, LAKSHMI · 2000 to 2022
$21.3M
NCRR NIH HHS P20 RR016480NIGMS NIH HHS R25 GM061222NIGMS NIH HHS S06 GM008136
6 · The paper itself

Abstract

Physiological experimentation, transcriptomics, and metabolomics were engaged to compare a fusidic acid-resistant

Indexed as

fusidic acid-resistancemetabolomicsrespirationStaphylococcus aureustranscriptional profiling

Identifiers

PMID36009920
PMCPMC9405211
OpenAlexW4289704730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.